Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2025-12-26 @ 2:23 AM
Study NCT ID:
NCT01068002
Status:
COMPLETED
Last Update Posted:
2020-02-12
First Post:
2010-02-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Cardiovascular an Echocardiographic Assessment in Hypertension During Pregnancy
Sponsor:
HaEmek Medical Center, Israel
Organization:
Study Overview
Official Title:
Hypertension During Pregnancy: Cardiovascular & Echocardiographic Assessment: CREATION - P (01)
Status:
COMPLETED
Status Verified Date:
2020-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CREATION-P
Brief Summary:
Cardiovascular \& echocardiographic assessment in pregnant women with hypertension during their pregnancy in comparison to Pregnant normotensive women.
Detailed Description:
Cardiovascular \& echocardiographic assessment in pregnant women with hypertension during their pregnancy in comparison to Pregnant normotensive women. Also,comparing echocardiographic parameters in hypertensive pregnant women being treated with either alfa methyl dopa or labetolol.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: